Intellia Therapeutics Inc

10 de set. de 2026, 19:16 UTC

Intellia Therapeutics Inc shares are lower today, following a notable decline from Wednesday's close amid broader market sentiment after the ECB raised interest rates.

8 de set. de 2026, 20:07 UTC

Intellia Therapeutics' shares decline despite FDA accepting its lonvo-z application for Priority Review, targeting a decision by March 2027.

3 de set. de 2026, 19:16 UTC

Intellia Therapeutics shares are lower, reflecting sector pressure and a notable decline in first-quarter results. Correlated asset CRISPR Therapeutics also experienced a downturn.

1 de set. de 2026, 20:09 UTC

Intellia Therapeutics is lower today, tracking broader market declines amid rising oil prices and increased U.S. Treasury yields, which raise inflation concerns.

31 de ago. de 2026, 23:21 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, recovering from recent declines and positioned above their 20-day moving average.

28 de ago. de 2026, 20:08 UTC

Intellia Therapeutics shares are lower today, continuing a recent downward trend amid rising U.S. Treasury yields and broader market weakness. No specific news was identified.

27 de ago. de 2026, 23:41 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, recovering from an earlier dip and surpassing their 20-day moving average. No specific news was identified.

26 de ago. de 2026, 23:11 UTC

Intellia Therapeutics Inc is higher in after-market hours, reflecting broader market gains. The asset remains above its 20-day moving average and near its one-month range.

25 de ago. de 2026, 20:09 UTC

Citizens reiterated its Market Outperform rating on Intellia Therapeutics and maintained a $30 price target, contributing to positive sentiment and higher shares.

24 de ago. de 2026, 23:01 UTC

Intellia Therapeutics shares declined after-market, moving lower from Monday's close. The stock remains above its 20-day moving average and near its one-month range.

21 de ago. de 2026, 23:56 UTC

Intellia Therapeutics shares are higher in after-market trading, reflecting a broader market rebound following a recent yield-driven selloff.

20 de ago. de 2026, 19:26 UTC

Intellia Therapeutics shares are lower, reflecting declines in the biotechnology sector and the Russell 2000 Index amid challenging market conditions.

19 de ago. de 2026, 20:02 UTC

Intellia Therapeutics shares are higher today, reflecting strong investor interest and positive sentiment in the genomics sector, aided by gains in ARK and CRSP.

17 de ago. de 2026, 19:36 UTC

Intellia Therapeutics Inc shares are higher, continuing an upward trend since Friday amid positive sentiment in the biotechnology sector and rising long-term Treasury yields.

14 de ago. de 2026, 23:31 UTC

Intellia Therapeutics Inc. shares rose in after-market trading, reflecting positive market dynamics. The stock remains above its 20-day moving average.

11 de ago. de 2026, 19:33 UTC

Intellia Therapeutics shares are lower after Brookline Capital Markets revised Q2 2026 earnings estimates to a loss of -$0.80 per share.

10 de ago. de 2026, 19:46 UTC

Intellia Therapeutics shares rise as analysts boost price targets, with Wedbush raising its target to $17.00 while maintaining a “neutral” rating.

7 de ago. de 2026, 19:26 UTC

Evercore ISI upgraded Intellia Therapeutics to Outperform and raised its price target to $24, contributing to gains in the stock during Friday's session.

6 de ago. de 2026, 23:06 UTC

Intellia Therapeutics Inc shares are higher in after-market hours, reflecting increased trading activity despite being near the lower end of its one-month range.

4 de ago. de 2026, 19:36 UTC

Shares higher today, reflecting gains in SPDR S&P Biotech ETF.

3 de ago. de 2026, 19:36 UTC

Intellia Therapeutics Inc. shares are trading higher amid broader small-cap market strength, recovering from an earlier dip during Monday's session.

31 de jul. de 2026, 20:06 UTC

Intellia Therapeutics Inc shares are lower today, reflecting broader sector pressures amid rising Treasury yields and inflation concerns.

30 de jul. de 2026, 17:57 UTC

Shares higher today, supported by Invesco WilderHill Clean Energy ETF.

29 de jul. de 2026, 23:31 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, reflecting positive sentiment in small-cap stocks amid broader market trends and the Fed's interest rate decision.

28 de jul. de 2026, 18:36 UTC

Intellia Therapeutics Inc. shares are trading roughly flat with no specific news identified. The stock remains below its 20-day moving average.

27 de jul. de 2026, 23:46 UTC

Intellia Therapeutics shares are higher in after-market trading, amid positive sentiment in European markets as the DAX rises.

25 de jul. de 2026, 00:02 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, reflecting positive movement in the biotechnology sector amid broader market stability.

24 de jul. de 2026, 13:31 UTC

Intellia Therapeutics Inc shares are higher in pre-market trading, advancing since Thursday's close despite being significantly below its 20-day moving average.

23 de jul. de 2026, 19:16 UTC

Intellia Therapeutics shares are higher Thursday, recovering from an earlier pullback amid a challenging tech sector backdrop following disappointing earnings from major companies.

22 de jul. de 2026, 23:56 UTC

Intellia Therapeutics Inc shares are higher in after-market trading, though they remain below their 20-day moving average and near the lower end of their one-month range.